Related Experiment Video
Updated: Dec 2, 2025

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
Hereditary Hemorrhagic Telangiectasia and Refractory Ascites
Ragesh B Thandassery1, Rahul S Patel2, Priya Grewal1
1Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York City, NY.
Abstract:
Hereditary hemorrhagic telangiectasia is a rare autosomal dominant disease that can involve the liver. The presence of arteriohepatic venous shunts can lead to high output cardiac failure and biliary ischemia, whereas arterioportal venous shunts can result in portal hypertension. Cirrhosis and nodular regenerative hyperplasia are also reported in these patients. Management of these patients in the setting of symptomatic liver disease is challenging. Transarterial embolization and hepatic artery ligation are usually considered palliative options. In selected cases, orthotopic liver transplantation can cure both liver disease and heart failure.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Varices-I: Introduction
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose Veins I: Introduction

